January 2026
1. MIYAKITA H, Ogimi T, Kayano H, Mori M, et al
   Changes in Tumor-Infiltrating Lymphocytes and Inflammatory Blood Factors during Chemoradiation Therapy in Rectal Cancer.
   Oncology. 2026;104:137-144.
   

   >> Share

   
   December 2025
2. FORMICA V, Morelli C, Rofei M, Sansone M, et al
   Clinicomics for predicting HER2 expression in metastatic colorectal cancer: a multicenter machine learning analysis on real-world data.
   Oncology. 2025 Dec 4:1-24. doi: 10.1159/000549661.
   

   >> Share

   
   May 2025
3. NUMATA K, Ono Y, Iguchi K, Uchiyama M, et al
   Prognostic significance of modified Glasgow Prognostic Score in patients undergoing FOLFOXIRI plus bevacizumab therapy for advanced or metastatic colorectal cancer.
   Oncology. 2025 May 26:1-22. doi: 10.1159/000546260.
   

   >> Share

   
   
4. KEMNA R, Zeeuw JM, Ziesemer KA, Ali M, et al
   From development to implementation: a systematic review on the current maturity status of artificial intelligence models for patients with colorectal cancer liver metastases.
   Oncology. 2025 May 26:1-25. doi: 10.1159/000546572.
   

   >> Share

   
   March 2025
5. KIM KM, Moon WS, Ha GW, Park HS, et al
   Clinicopathological significance of APC mutation in patient with colorectal cancer.
   Oncology. 2025 Mar 13:1-17. doi: 10.1159/000545255.
   

   >> Share

   
   
6. DOLCI M, Civettini I, Bagnoli PF, Toumi W, et al
   Expression of Human Endogenous Retrovirus env-gene product is a hallmark of sidedness in operable colorectal cancer.
   Oncology. 2025 Mar 11:1-16. doi: 10.1159/000543099.
   

   >> Share

   
   August 2024
7. LIANG Y, Li Y, Guo R, Zhao Y, et al
   Identification and initial validation of neuroendocrine differentiation as a novel prognostic factor in stage II colorectal cancer patients.
   Oncology. 2024 Aug 19. doi: 10.1159/000540936.
   

   >> Share

   
   
8. DIMBERG J, Shamoun L, Af Geijerstam K, Landerholm K, et al
   Significance of Gene Polymorphism and Gene Expression of BACE2 in Swedish Patients with Colorectal Cancer.
   Oncology. 2024 Aug 14:1-8. doi: 10.1159/000540887.
   

   >> Share

   
   July 2024
9. ZHOU J, Nie H, Yang X, Wang F, et al
   Ubiquitin-specific protease 52 as a prognostic biomarker correlates with tumor microenvironment and therapy response in colorectal cancer.
   Oncology. 2024 Jul 24. doi: 10.1159/000540441.
   

   >> Share

   
   
10. ERCIYESTEPE M, Selvi O, Dinc G, Ozturk AE, et al
    Factors affecting recurrence and survival in Stage IIA colon cancer patients.
    Oncology. 2024 Jul 15. doi: 10.1159/000540334.
    

    >> Share

    
    June 2024
11. ALKAN A, Doganer GI, Tanriverdi O
    Serum Uric Acid Level May Be A Predictive Factor For BRAF V600E Mutation In Older Patients With Metastatic Colorectal Cancer: An Exploratory Analysis.
    Oncology. 2024 Jun 27. doi: 10.1159/000539981.
    

    >> Share

    
    January 2024
12. WU HQ, Li J, Miao JD, Li JW, et al
    Is Total Neoadjuvant Treatment Beneficial for Locally Advanced Rectal Cancer? A Meta-Analysis of Randomized Controlled Trials.
    Oncology. 2024;102:399-413.
    

    >> Share

    
    
13. ROMERO ZOGHBI SE, Martin Martin M, Garcia JC, Valero M, et al
    Total Neoadjuvant Therapy Approach for the Treatment of Locally Advanced Rectal Cancer: Where Do We Stand?
    Oncology. 2024;102:646-658.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share